Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
CCU, OR, PACU, CCL, ED
PCU
2N (Tele)
1N (Tele), 3N (Tele)
Med/Surg (1N w/o Tele, 3N w/o Tele, 4N, 5N)
BirthPlace
SNF
ICS
OPS
enalapril (Vasotec) IV Push
Y
Y
Y
Y
Y
Y
Y
Y
Y
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
enalapril (Vasotec)
Criteria 4: Potentially clinically important drug-drug interactions that should be avoided in older adults. (Table 5)
Interacting drug(s) or class(es)
RAS inhibitors (ACEIs ARBs, ARNIs, aliskiren) ⇄ Another RAS inhibitor or a potassium-sparing diuretic
Risk Rationale
Increased risk of hyperkalemia.
Recommendation
Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.
Quality of evidence: Moderate, Strength of Recommendation: Strong
(KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
IV Push